Search

Search Constraints

You searched for: Author/Creator Kantoff, Philip W.

Search Results

1. A dose finding clinical trial of cabozantinib (XL184) administered in combination with abiraterone acetate in metastatic castration‐resistant prostate cancer. Issue 14 (7th June 2018)

3. A phase 2 trial of abiraterone acetate without glucocorticoids for men with metastatic castration‐resistant prostate cancer. Issue 4 (14th November 2018)

4. Androgen Deprivation Therapy Reversibly Increases Endothelium‐Dependent Vasodilation in Men With Prostate Cancer. Issue 4 (20th April 2015)

5. Androgen Deprivation Therapy Reversibly Increases Endothelium‐Dependent Vasodilation in Men With Prostate Cancer. Issue 4 (April 2015)

8. Benchmarks for Academic Oncology Faculty. Issue 3 (March 2021)

9. Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality. Issue 11 (10th May 2022)